Rationale for cardiovascular medicine to separate from internal medicine and become an independent specialty Steven E. Nissen Invited Commentary 09 January 2009 Pages: 431 - 432
Treating hypertension in the very elderly Ronald G. Victor Clinical Trials Report 09 January 2009 Pages: 437 - 439
Are we getting closer to a Nobel Prize for unraveling preeclampsia? Ralf DechendFriedrich C. Luft OriginalPaper 09 January 2009 Pages: 440 - 447
Potential risks of calcium channel blockers in chronic kidney disease Karen A. GriffinAnil K. Bidani OriginalPaper 09 January 2009 Pages: 448 - 455
Neural mechanisms and management of obesity-related hypertension Murray D. EslerNina EikelisNora Straznicky OriginalPaper 09 January 2009 Pages: 456 - 463
Is hypertension an immunologic disease? David G. HarrisonTomasz J. GuzikCornelia Weyand OriginalPaper 09 January 2009 Pages: 464 - 469
In hypertension, the kidney breaks your heart Steven D. CrowleyThomas M. Coffman OriginalPaper 09 January 2009 Pages: 470 - 476
LDL reduction: How low should we go and is it safe? Jennifer G. Robinson OriginalPaper 09 January 2009 Pages: 481 - 487
When high is low: Raising low levels of high-density lipoprotein cholesterol Peter P. Toth OriginalPaper 09 January 2009 Pages: 488 - 496
Biomarkers of atherosclerosis: Clinical applications Todd M. BrownVera Bittner OriginalPaper 09 January 2009 Pages: 497 - 504
The role of triglycerides in cardiovascular risk Puneet GandotraMichael Miller OriginalPaper 09 January 2009 Pages: 505 - 511
LDL-C-Lowering therapy: Current and future therapeutic targets Maartje E. VisserLily JakuljErik S. G. Stroes OriginalPaper 09 January 2009 Pages: 512 - 520
Atherosclerosis surrogate imaging trials come of age: For better or for worse? Michael H. DavidsonEwa Dembowski OriginalPaper 09 January 2009 Pages: 521 - 525
